Bo Ning
Bo Ning
Stealth ModeBo Ning is an Assistant Professor at Tulane University School of Medicine, researching infectious disease diagnostics.
About
What does Bo Ning do?
Bo Ning is an Assistant Professor in the Department of Biochemistry and Molecular Biology at Tulane University School of Medicine. His research focuses on developing novel diagnostic technologies for infectious diseases, including CRISPR-based tests for mycobacteria and SARS-CoV-2 variants. He has also been involved in research related to tuberculosis detection and exosome markers for cancer metastasis.
Where is Bo Ning headquartered?
Bo Ning is headquartered in New Orleans, United Kingdom.
When was Bo Ning founded?
Bo Ning was founded in 2026.
What industry does Bo Ning operate in?
Bo Ning operates in Biotech, HealthTech, Diagnostics, CRISPR Technology, Infectious Disease Research.
An independent research reference providing accessible, accurate, and transparent information on bioactive peptides and peptide science.
Provider-supervised peptide therapy, NAD+ support, and cognitive enhancement for cellular renewal, recovery, and healthy aging.
Leading AI agency in Guwahati specializing in biological intelligence, generative AI, and regulatory systems for Asia's underrepresented populations.
Spearmint Resources Inc. is a Canadian mineral exploration company focused on lithium, gold, and antimony projects.
Eccoscience is a startup focused on developing AI-powered solutions for scientific research and discovery.
Feef is a voice-native AI agent that designs personalized fitness, nutrition, supplement, and recovery protocols, integrating them directly into your calendar.
Longevity and metabolic health platform offering personalized insights and interventions.
AI-powered platform for personalized health and longevity.
An entrant is a company tagged Biotech whose domain was first registered in the window, counted from registry records in the StartupHub directory. 1 of them registered in the last 30 days. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.